エピソード

  • Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes
    2026/10/13

    Tianyu Cao, Michael Fang, Amelia S Wallace, Natalie Daya Malek, Arielle Valint, Dan Wang, Justin B Echouffo-Tcheugui, Scott L Zeger, Elizabeth Selvin. Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes. Clinical Chemistry, Volume 72, Issue 10, October 2026, Pages 1039–1045. https://doi.org/10.1093/clinchem/hvag067

    続きを読む 一部表示
    11 分
  • Mining and Refining Elusive Microproteins from Noncanonical Open Reading Frames
    2026/10/13

    Yifei K Yang. Mining and Refining Elusive Microproteins from Noncanonical Open Reading Frames. Clinical Chemistry, Volume 72, Issue 10, October 2026, Pages 1101–1103. https://doi.org/10.1093/clinchem/hvag107

    続きを読む 一部表示
    18 分
  • Point of Concern for Troponin Testing with High-Sensitivity Assays in the Near Patient Setting
    2026/09/25

    Peter A Kavsak. Point of Concern for Troponin Testing with High-Sensitivity Assays in the Near Patient Setting, Clinical Chemistry, 2026; 72(10): hvag034. https://doi.org/10.1093/clinchem/hvag034

    続きを読む 一部表示
    12 分
  • October 2026 Audio Summary
    5 分
  • Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neurodegenerative Diseases Using Peripheral Tissues
    2026/09/10

    Melissa Ix, Richard Dodel, J Alexander Ross. Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neurodegenerative Diseases Using Peripheral Tissues. Clinical Chemistry, Volume 72, Issue 8, August 2026, Pages 830–844. https://doi.org/10.1093/clinchem/hvag037

    続きを読む 一部表示
    9 分
  • Predictive Biomarkers for Immune Checkpoint Inhibitor Efficacy: Challenges, Innovations, and a Pathway to Precision Medicine in the Era of Cancer Immunotherapy
    2026/09/10

    Matthew Lee, Jeffrey A SoRelle, Arun Everest-Dass, David E Gerber, Mitchell S von Itzstein. Predictive Biomarkers for Immune Checkpoint Inhibitor Efficacy: Challenges, Innovations, and a Pathway to Precision Medicine in the Era of Cancer Immunotherapy. Clin Chem 2026; 72(9): 926–47. https://doi.org/10.1093/clinchem/hvag062

    続きを読む 一部表示
    15 分
  • Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymphoma
    2026/09/01

    Shengjie Li, Jiazhen Cao, Jun Ren, Kun Chen, Jianing Wu, Yingzhu Li, Yunxiao Song, Chengxun Li, Wenjun Cao, Ming Guan. Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymphoma. Clin Chem 2026; 72(8): 880–92.

    https://doi.org/10.1093/clinchem/hvag036

    続きを読む 一部表示
    13 分
  • Audio Summary September 2026
    5 分